Discover 359 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 359
FeaturedActive & Responsive
Brief Skills for Safer Living (Brief-SfSL)
for
Suicide Prevention, Suicide, Suicide and Self-harm
1 location in Quebec City
Sponsor: Unity Health Toronto
Sex: All
Age: 18+
Code: NCT06571916
Recruiting
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
for
Cervical Cancer
0 location in Quebec
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18 - 40
Code: NCT04016389
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
0 location in Quebec
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
Cranial Nerve Neuromodulation to Improve Arm Function and Brain Plasticity in Stroke
for
Stroke
0 location in Quebec
Sponsor: Université de Sherbrooke
Sex: All
Age: 18 - 70+
Code: NCT06386510
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
0 location in Quebec
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
Impact of Dairy Integration Into Canadian Food Guide on Gut Health
for
Gut Epithelial Permeability,
0 location in Quebec
Sponsor: Laval University
Sex: All
Age: 40 - 65
Code: NCT07257913
Recruiting
Active & Responsive
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis
0 location in Quebec
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07027527
Phase1, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease